Table 1.
List of 20 articles with the highest citation rate in the area of total body irradiation. TI, title; TC, total citations; C/Y, citations rate per year.
| Citation | TI | TC | C/Y | IF |
|---|---|---|---|---|
| MATTHAY KK, 1999, NEW ENGL J MED | TREATMENT OF HIGH-RISK NEUROBLASTOMA WITH INTENSIVE CHEMOTHERAPY, RADIOTHERAPY, AUTOLOGOUS BONE MARROW TRANSPLANTATION, AND 13-CIS-RETINOIC ACID (25) | 1425 | 57 | 176.1 |
| MCSWEENEY PA, 2001, BLOOD | HEMATOPOIETIC CELL TRANSPLANTATION IN OLDER PATIENTS WITH HEMATOLOGIC MALIGNANCIES: REPLACING HIGH-DOSE CYTOTOXIC THERAPY WITH GRAFT-VERSUS-TUMOR EFFECTS (26) | 1100 | 47.83 | 22.1 |
| THOMAS ED, 1977, BLOOD | 100 PATIENTS WITH ACUTE-LEUKEMIA TREATED BY CHEMOTHERAPY, TOTAL-BODY IRRADIATION, AND ALLOGENEIC MARROW TRANSPLANTATION (27) | 1011 | 21.51 | 22.1 |
| DUDLEY ME, 2008, J CLIN ONCOL | ADOPTIVE CELL THERAPY FOR PATIENTS WITH METASTATIC MELANOMA: EVALUATION OF INTENSIVE MYELOABLATIVE CHEMORADIATION PREPARATIVE REGIMENS (28) | 1007 | 62.94 | 50.7 |
| CHANG JH, 2016, NAT MED | CLEARANCE OF SENESCENT CELLS BY ABT263 REJUVENATES AGED HEMATOPOIETIC STEM CELLS IN MICE (29) | 963 | 120.38 | 87.2 |
| HALL EJ, 2003, INT J RADIAT ONCOL | RADIATION-INDUCED SECOND CANCERS: THE IMPACT OF 3D-CRT AND IMRT (30) | 944 | 44.95 | 8 |
| AVERSA F, 1998, NEW ENGL J MED | TREATMENT OF HIGH-RISK ACUTE LEUKEMIA WITH T-CELL-DEPLETED STEM CELLS FROM RELATED DONORS WITH ONE FULLY MISMATCHED HLA HAPLOTYPE (31) | 919 | 35.35 | 176.1 |
| TAYLOR PA, 2002, BLOOD | THE INFUSION OF EX VIVO ACTIVATED AND EXPANDED CD4(+)CD25(+) IMMUNE REGULATORY CELLS INHIBITS GRAFT-VERSUS-HOST DISEASE LETHALITY (32) | 845 | 38.41 | 22.1 |
| CURTIS RE, 1997, NEW ENGL J MED | SOLID CANCERS AFTER BONE MARROW TRANSPLANTATION (33) | 674 | 24.96 | 176.1 |
| LAUGHLIN MJ, 2001, NEW ENGL J MED | HEMATOPOIETIC ENGRAFTMENT AND SURVIVAL IN ADULT RECIPIENTS OF UMBILICAL-CORD BLOOD FROM UNRELATED DONORS (34). | 673 | 29.26 | 176.1 |
| HILL GR, 1997, BLOOD | TOTAL BODY IRRADIATION AND ACUTE GRAFT-VERSUS-HOST DISEASE: THE ROLE OF GASTROINTESTINAL DAMAGE AND INFLAMMATORY CYTOKINES (35) | 663 | 24.56 | 22.1 |
| MATTHAY KK, 2009, J CLIN ONCOL | LONG-TERM RESULTS FOR CHILDREN WITH HIGH-RISK NEUROBLASTOMA TREATED ON A RANDOMIZED TRIAL OF MYELOABLATIVE THERAPY FOLLOWED BY 13-CIS-RETINOIC ACID: A CHILDREN’S ONCOLOGY GROUP STUDY (36) | 620 | 41.33 | 50.7 |
| SPIELBERGER R, 2004, NEW ENGL J MED | PALIFERMIN FOR ORAL MUCOSITIS AFTER INTENSIVE THERAPY FOR HEMATOLOGIC CANCERS (37) | 592 | 29.6 | 176.1 |
| BENSINGER W, 1995, J CLIN ONCOL | FACTORS THAT INFLUENCE COLLECTION AND ENGRAFTMENT OF AUTOLOGOUS PERIPHERAL-BLOOD STEM-CELLS (38) | 585 | 20.17 | 50.7 |
| GIRALT S, 2009, BIOL BLOOD MARROW TR | REDUCED-INTENSITY CONDITIONING REGIMEN WORKSHOP: DEFINING THE DOSE SPECTRUM. REPORT OF A WORKSHOP CONVENED BY THE CENTER FOR INTERNATIONAL BLOOD AND MARROW TRANSPLANT RESEARCH (39) | 573 | 38.2 | 5.7 |
| BENSINGER WI, 1995, BLOOD | TRANSPLANTATION OF ALLOGENEIC PERIPHERAL-BLOOD STEM-CELLS MOBILIZED BY RECOMBINANT HUMAN GRANULOCYTE-COLONY-STIMULATING FACTOR (40) | 570 | 19.66 | 22.1 |
| DEVINE SM, 2003, BLOOD | MESENCHYMAL STEM CELLS DISTRIBUTE TO A WIDE RANGE OF TISSUES FOLLOWING SYSTEMIC INFUSION INTO NONHUMAN PRIMATES (41) | 570 | 27.14 | 22.1 |
| AVERSA F, 2005, J CLIN ONCOL | FULL HAPLOTYPE-MISMATCHED HEMATOPOIETIC STEM-CELL TRANSPLANTATION: A PHASE II STUDY IN PATIENTS WITH ACUTE LEUKEMIA AT HIGH RISK OF RELAPSE (42) | 543 | 28.58 | 50.7 |
| BURDELYA LG, 2008, SCIENCE | AN AGONIST OF TOLL-LIKE RECEPTOR 5 HAS RADIOPROTECTIVE ACTIVITY IN MOUSE AND PRIMATE MODELS (43) | 529 | 33.06 | 40.7 |
| LAWRENCE TS, 1995, INT J RADIAT ONCOL | HEPATIC TOXICITY RESULTING FROM CANCER-TREATMENT (44) | 506 | 17.45 | 8 |